Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 18,750 shares at $27.98 ($525K) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Scheduled sale ($525k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |
| BCAX | SELL | 2026-03-17 | $491K | — | Filing → |